Tijana
Tijana Filipova, Berlin DE
Patent application number | Description | Published |
---|---|---|
20140079539 | Turbine blade of a gas turbine with swirl-generating element and method for its manufacture - The present invention relates to a turbine blade of a gas turbine with an airfoil arranged on a blade root and having at least one cooling air duct running in the longitudinal direction of the turbine blade, arranged inside the turbine blade and extending through the blade root, characterized in that at least one swirl-generating element is arranged in the transitional area between blade root and airfoil in the cooling air duct, with the swirl-generating element including an outer ring and several swirl-generating stator vanes arranged thereon, which are connected to a centric area, as well as to a method for its manufacture. | 03-20-2014 |
Tijana Rajh, Naperville, IL US
Patent application number | Description | Published |
---|---|---|
20110039341 | Method for detecting nucleotide polymor-phisms using semiconductor particles - A method for detecting anomalies in genetic material is provided, the method comprising supplying the genetic material; establishing electronic communication between the genetic material and a semi-conductor particle so as to create a composite; contacting the composite with a first metal ion; and subjecting the contacted composite to energy in an amount and for a time sufficient to reduce the first metal ion to a first elemental metal. Also provided is a device for detecting single nucleotide mismatching in genetic material, the device comprising a semiconductor particle; a ligand attached to the particle; the genetic material in electronic communication with the ligand so as to form an organic-inorganic composite; metal ion in electronic communication with the composite, such that the metal ion reduces to elemental metal when the semiconductor particle is exposed to radiation of a predetermined energy level. | 02-17-2011 |
20140212733 | HIGH CAPACITY ELECTRODE MATERIALS FOR BATTERIES AND PROCESS FOR THEIR MANUFACTURE - The present invention provides a nanostructured metal oxide material for use as a component of an electrode in a lithium-ion or sodium-ion battery. The material comprises a nanostructured titanium oxide or vanadium oxide film on a metal foil substrate, produced by depositing or forming a nanostructured titanium dioxide or vanadium oxide material on the substrate, and then charging and discharging the material in an electrochemical cell from a high voltage in the range of about 2.8 to 3.8 V, to a low voltage in the range of about 0.8 to 1.4 V over a period of about 1/30 of an hour or less. Lithium-ion and sodium-ion electrochemical cells comprising electrodes formed from the nanostructured metal oxide materials, as well as batteries formed from the cells, also are provided. | 07-31-2014 |
Tijana Rajh, Downers Grove, IL US
Patent application number | Description | Published |
---|---|---|
20100078066 | HYBRID SOLAR CELLS VIA UV-POLYMERIZATION OF POLYMER PRECURSOR - A hybrid photovoltaic cell comprising a composite substrate of a nanotube or nanorod array of metal oxide infiltrated with a monomer precursor and subsequently polymerized in situ via UV irradiation. In an embodiment, the photovoltaic cell comprises an electron accepting TiO | 04-01-2010 |
Tijana Stanic Ljubin, Ljubljana SI
Patent application number | Description | Published |
---|---|---|
20090291136 | Multiple Unit Tablets - The present invention relates to multiple unit tablets comprising multiple units compacted together with at least two tablet filler-binders and optionally other pharmaceutically acceptable excipients, wherein at least one of said tablet filler-binder is a tablet filler-binder having mean particle size-to-mean multiple unit size ratio from 10% to 40%, and at least one of said tablet filler-binder is a tablet filler-binder having mean particle size-to-mean multiple unit size ratio from 1% to 10%. | 11-26-2009 |
20100120868 | Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate - The invention relates to a process for preparing a solid pharmaceutical composition rosiglitazone maleate, comprising the step of adsorption of rosiglitazone maleate onto carrier particles (C) during a dry mixing process. | 05-13-2010 |
20130059002 | PHARMACEUTICAL COMPOSITIONS COMPRISING A COMBINATION OF METFORMIN AND SITAGLIPTIN - The present invention relates to a pharmaceutical composition, preferably a pharmaceutical dosage form, comprising at least two separate compartments, wherein one compartment contains a composition comprising metformin or a pharmaceutically acceptable salt thereof and wherein another compartment contains a composition comprising sitagliptin. | 03-07-2013 |
20140044783 | PHARMACEUTICAL COMPOSITION COMPRISING A THIAZOLIDINEDIONE - A pharmaceutical composition comprises a combination of thiazolidinedione or a pharmaceutically acceptable salt thereof as a first pharmaceutically active ingredient and a second pharmaceutically active ingredient different from thiazolidinedione, wherein the amount of said second pharmaceutically ingredient is larger than that of the first pharmaceutically active ingredient, and wherein the combination of said first and second pharmaceutically active ingredients are provided by a first granulate comprising the first and second pharmaceutically active ingredients and optionally at least one excipient, said first granulate being present in a second granulate comprising a further pharmaceutical excipient. | 02-13-2014 |
20140248351 | PHARMACEUTICAL COMPOSITION COMPRISING FESOTERODINE - The present invention relates to a granulate and a pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof and stabilizer, in particular to a pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof and sucrose, polyethylene glycol, cyclodextrin, and combinations thereof and to a process for its preparation. The granulate and the pharmaceutical composition are particularly useful as a medicament, especially for the treatment of urinary incontinence. The present invention relates to use of sucrose, polyethylene glycol, cyclodextrin, and combinations thereof for stabilizing fesoterodine or a salt or a solvate thereof in a pharmaceutical composition. | 09-04-2014 |